Ocular Anesthesia-Related Closed Claims from Ophthalmic Mutual Insurance Company 2008–2018

Ocular Anesthesia-Related Closed Claims from Ophthalmic Mutual Insurance Company 2008–2018

Journal Pre-proof Ocular Anesthesia-Related Closed Claims from Ophthalmic Mutual Insurance Company 2008-2018 Michael Morley, MD, ScM, Anne M. Menke, R...

547KB Sizes 0 Downloads 18 Views

Journal Pre-proof Ocular Anesthesia-Related Closed Claims from Ophthalmic Mutual Insurance Company 2008-2018 Michael Morley, MD, ScM, Anne M. Menke, RN, PhD, Karen C. Nanji, MD, MPH PII:

S0161-6420(19)32371-1

DOI:

https://doi.org/10.1016/j.ophtha.2019.12.019

Reference:

OPHTHA 11043

To appear in:

Ophthalmology

Received Date: 12 November 2019 Revised Date:

13 December 2019

Accepted Date: 18 December 2019

Please cite this article as: Morley M, Menke AM, Nanji KC, Ocular Anesthesia-Related Closed Claims from Ophthalmic Mutual Insurance Company 2008-2018 Ophthalmology (2020), doi: https:// doi.org/10.1016/j.ophtha.2019.12.019. This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record. This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we are providing this version to give early visibility of the article. Please note that, during the production process, errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain. © 2019 Published by Elsevier Inc. on behalf of the American Academy of Ophthalmology

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46

Ocular Anesthesia-Related Closed Claims from Ophthalmic Mutual Insurance Company 2008-2018

Michael Morley, MD, ScM1* Anne M. Menke, RN, PhD2* Karen C. Nanji, MD, MPH3

*

These authors contributed equally to this manuscript.

1

Ophthalmic Consultants of Boston, Harvard Medical School, Boston, MA Ophthalmic Mutual Insurance Company, San Francisco, CA 3 Massachusetts General Hospital, Harvard Medical School, Boston, MA 2

Address correspondence to: Michael Morley MD, ScM, Ophthalmic Consultants of Boston 50 Staniford St., Suite 600 Boston, MA 02114 [email protected] 617-367-4800 x 6083

47

Abstract

48

Purpose: To evaluate the types of anesthesia-related closed claims and their contributing

49

factors, using data from Ophthalmic Mutual Insurance Company (OMIC).

50

Design: Retrospective analysis of pre-existing data

51

Participants: Plaintiffs who filed a professional liability claim or suit (written demand for

52

money) against OMIC-insured ophthalmologists, ophthalmic practices, and/or surgicenters in

53

which the surgical case occurred.

54

Methods: Plaintiff claims were collected from the OMIC database from 2008-2018 using search

55

queries for terms associated with known complications of ophthalmic anesthesia.

56

Main outcome measures: Number and types of anesthesia-related injuries and claims, who

57

administered the anesthesia, the outcomes of the claim or suit, cost to defend, and payments

58

made to plaintiffs.

59

Results: Sixty-three anesthesia related claims or suits were filed by 50 plaintiffs. Anesthesia-

60

related injuries included globe perforation (n=17), death (n=13), retrobulbar hemorrhage (n=7),

61

optic nerve damage (n=4), vascular occlusions (n=2), pain (n=2), eye or head movement

62

resulting in injury (n=2), and one case each for numbness, diplopia, and tooth loss during

63

intubation. All but 1 patient who died had pre-existing, significant co-morbidities. Two deaths

64

were related to brainstem anesthesia.

65

Regarding the type of anesthesia in the closed claims, retrobulbar and peribulbar anesthesia

66

were the most common types (n=16 each ), followed by local infiltration around the lids and

67

facial nerve (n=6), topical anesthesia (n=5) and general anesthesia (n=5). In two cases, the

68

exact type of anesthesia was unknown but not general. The 5 topical with sedation anesthesia2

69

related claims were due to inadequate pain control (n= 2), ocular movement resulting in

70

capsular rupture (n= 2), or death (n=1) allegedly related to excessive, or inadequate monitoring

71

of, sedation. There were 5 claims related to general anesthesia including 4 deaths and 1 tooth

72

loss during intubation. Sedation was alleged to be a factor in 5 cases resulting in death.

73

Anticoagulants were a factor in 3 retrobulbar hemorrhage cases.

74

Conclusions: While claims and suits were infrequent given the large number of insured

75

ophthalmologists and the large number of surgical cases requiring various types of anesthesia

76

performed over the 10.5-year study period, severe injuries can occur.

77 78

3

79

Introduction

80

Ophthalmic surgery typically yields good outcomes and is well-tolerated by the vast majority of

81

patients. The safety of the various ocular surgery anesthesia options contributes to the

82

excellent safety profile of ophthalmic surgery. However, severe injuries related to ocular

83

anesthesia do occur, 1-4 and these injuries can result in medical malpractice claims made against

84

the ophthalmologist, ophthalmology practice, anesthesiologist, nurse anesthetist, or the

85

surgical facility in which the surgery occurred. A better understanding of the frequency and

86

types of anesthesia-related claims may help to guide safety efforts to prevent patient harm

87

during ophthalmic surgery. Ophthalmic Mutual Insurance Company (OMIC) insures over 5,300

88

ophthalmologists, or about half of the ophthalmologists in private practice in the USA, as well

89

as their surgicenters and practices, making this data set helpful in evaluating anesthesia-related

90

complications that result in malpractice claims. 5 The purpose of this paper is to evaluate the

91

types of anesthesia-related closed claims and their contributing factors, using data from OMIC.

92 93

Methods

94

This is a retrospective analysis of closed (i.e., resolved) claims made against OMIC insureds for a

95

ten-year period from 6/1/2008-12/31/2018. A claim is defined as a written notice or demand

96

for money or services, including the institution of a lawsuit or arbitration proceeding. Our data

97

do not include open claims, i.e., claims that are filed but not yet resolved. Claims were

98

identified by author AMM searching the OMIC claims database for terms related to anesthesia

99

and complications from anesthesia including anesthesia, retrobulbar, peribulbar, topical, and

100

general anesthesia, globe perforation, perforation, penetration, death, bleeding, hemorrhage, 4

101

optic nerve, diplopia, double vision, stroke, heart attack, myocardial infarction, pain,

102

movement, and retrobulbar hemorrhage. Cases were selected if there was an allegation in the

103

claim of injury related to anesthesia or if the injury was clearly related to the administration of

104

anesthesia. All cases were then reviewed independently and then compared by 2 authors

105

(AMM and MGM) to confirm if there was an anesthesia-related complaint or injury.

106

Disagreements were resolved by consensus. We did not review patients’ medical records; the

107

data analyzed were the claims data summary and litigation files collected by OMIC Senior

108

Litigation Analysts and defense attorneys. Our data did not include claims regarding eye injuries

109

that may be anesthesia-related but occurred during non-ocular surgeries (e.g., anterior

110

ischemic optic neuropathy occurring during spine surgery, corneal abrasions occurring in

111

general anesthesia cases, etc.)

112 113

Statistical analysis

114

This study is a descriptive study with counts of individual events, means and ranges, or

115

proportions of total events presented. Because a single injury to a plaintiff may result in more

116

than 1 claim, data pertaining to claims use a denominator of number of claims and data

117

regarding injuries are presented with a denominator of number of patients. Comparisons

118

between groups were not performed. The rate of anesthesia-related ocular injuries was not

119

calculated given the lack of a denominator for total number of surgeries performed during the

120

time period.

121 122 5

123

Results

124

The demographics and descriptive data are presented in Table 1. Fifty patients submitted a

125

total of 63 claims or suits against OMIC-insured defendants including ophthalmologists, their

126

ophthalmology practices, and the surgical facilities in which the procedure took place. Plaintiffs

127

submitted an average of 1.26 claims with the surgeon, the surgeon’s practice, and/or the

128

surgicenter named as defendants. The average age of the plaintiff was 58 years old. Plaintiffs

129

gender included female (n =26, 51%), male (n= 21, 41%) and unknown (n=4, 8%). On average,

130

claims were filed 378 days (range 1-832 days, average 1.0 years) after the precipitating event,

131

and closed 1,290 days (range 433-3722 days, average 3.6 years) after the event.

132 133

Types of anesthesia resulting in injuries

134

Table 2 lists the data collected from our review of anesthesia-related closed claims cases.

135

Retrobulbar (n=16) or peribulbar (n=16) anesthesia were used in 32 (64%) of the plaintiff

136

injuries. Local anesthesia injected into the lids or periocular region was used in 6 (12%) cases.

137

General anesthesia was associated with 5 (10%) of the cases. Topical (eyedrop) anesthesia was

138

used in 5 (10%) cases. In two cases, the anesthesia type was uncertain but was not general (i.e.,

139

peribulbar, retrobulbar, local, or topical). In the 17 globe perforations, 10 patients received

140

retrobulbar anesthesia, 5 patients received peribulbar anesthesia, and 2 received an uncertain

141

type of anesthesia.

142 143

Administration of the retrobulbar and peribulbar blocks

6

144

Ophthalmologists administered the peribulbar or retrobulbar injection in 27 of 32 (84%) peri-

145

or retrobulbar anesthesia-related closed claim cases, while anesthesiologists administered 3

146

(9%) and CRNAs administered the injection in 2 (6%) cases. Of the 17 cases with globe

147

perforation, ophthalmologists performed the block in 12 (70%) while anesthesiologists

148

performed the block in 3 (18%), and a CRNA performed the block in 2 (12%).

149 150

Types of surgical cases/specialty resulting in claims

151

Cataract surgical procedures (n=24, 48%) were the most common type of case generating a

152

claim, followed by retina procedures (n=12, 24%) including vitrectomy and scleral buckle

153

surgery, laser procedures (n=5, 10%), oculoplastic cases (n = 4, 6%), pterygium (n = 3, 6%),

154

strabismus surgery (n=1, 2%) and chalazion incision and drainage (n=1, 2%). Four of the closed

155

claim injuries occurred in an office setting, 18 occurred in surgical settings (i.e., a hospital or

156

surgicenter operating room) and the remaining 18 case locations were not specified but

157

presumed to be in an operating room based on claim type.

158 159

Types of Injuries

160

Globe perforation was the most common plaintiff injury in our data set accounting for 17 (34%)

161

plaintiff injuries. Deaths accounted for 13 (26%) of the plaintiff injuries. Retrobulbar

162

hemorrhage resulting in blindness accounted for 7 (14%) of the injuries. Three of the plaintiffs

163

with retrobulbar hemorrhage were on anticoagulants, (1 warfarin, 1 apixaban, and 1 case

164

involved a combination of aspirin and clopidogrel). One plaintiff with bleeding had a low

165

platelet count discovered after the injury. Optic nerve injuries or perforation occurred in 4 (8%) 7

166

of the plaintiffs. All 4 optic nerve injuries resulted in post-operative pallor and legal blindness.

167

Additional injuries included vascular occlusions (n=2, 4%), movement of the eye or head during

168

surgery resulting in capsular rupture (n=2, 4%), and post-operative pain (n=2, 4%). Numbness,

169

diplopia, and tooth loss (n=1 each, 2% each) comprised the remaining injuries. There were no

170

wrong-sided or wrong type of anesthesia claims.

171 172

Of the 13 deaths, most plaintiffs had known medical problems including diabetes mellitus (DM),

173

(N=4, 31%), atherosclerotic cardiovascular disease (ASCVD)(N=1, 8%), or a combination of DM,

174

hypertension (HTN), ASCVD, or pulmonary edema (N=5, 38%). Despite the presence of these

175

conditions, all of the plaintiffs were classified as American Society of Anesthesiologists (ASA)

176

Physical Status III, defined as severe systemic disease with substantive functional limitations

177

from one or more moderate to severe disease. None were given the higher category IV of

178

severe systemic disease that is a constant threat to life.6 Three patients (23%) had a past

179

medical history that was not recorded in the OMIC database. Four of the 13 plaintiffs who died

180

had general anesthesia, 6 had retro- or peribulbar anesthesia, 1 had topical anesthesia with

181

sedation, and 2 were unknown but they did not have general anesthesia. In two of the deaths

182

following injection of retrobulbar anesthesia, the plaintiff suffered immediate respiratory arrest

183

and loss of consciousness. One case was attributed to brainstem anesthesia based on clinical

184

assessment. In the other case, the postmortem toxicology evaluation determined the cause.

185

The other deaths were attributed to cardiovascular disease (CVD, congestive heart failure,

186

pulmonary edema, myocardial infarction) or cerebrovascular (stroke) conditions; most of these

187

patients had known coexisting DM or CVD. General anesthesia injuries included 3 deaths and 1 8

188

tooth loss during intubation. The 38 cases with needle-based anesthesia (retrobulbar (n=17),

189

peribulbar (n=16), and local anesthesia (n=6)) led to globe perforation (n=17), death (n=6), optic

190

nerve injury (n=4), bleeding (n=7), diplopia (n=1), numbness (n=1), and central retinal artery

191

occlusion (n=2).

192 193

Indemnity payments and claim disposition

194

Sixteen of the 63 claims (25%) resulted in a payment to the plaintiff (indemnity payment) and

195

48 (75%) had no payment as the suit was either successfully defended or dismissed.

196

Perforations were the most common and most expensive injury resulting in a payment in 6

197

claims averaging $271,000 (range $20,000-$585,000). Death was the second most common

198

outcome resulting a payment in 5 claims averaging $73,500 (range $20,000-$160,000.) There

199

were 4 payments for retrobulbar hemorrhage cases averaging $92,500 (range $29,999-

200

$200,000.) Indemnity payments averaged $158,678 (median $75,000, range $15,000-

201

$585,000.) Of the 16 claims resulting in a payment, 14 were negotiated lump sum settlements,

202

1 was a negotiated annuity payment, and 1 case resulted from a plaintiff verdict at trial.

203

Of the 48 claims that settled with no payment, twenty-three claims were closed with no

204

payment before a lawsuit was filed, 4 lawsuits were closed after defense verdicts at trial, 5

205

were dismissed without prejudice, i.e., they could be refiled), 3 were dismissed for lack of

206

prosecution, 1 case was dismissed in summary judgement (i.e., decided by a judge not a jury),

207

and 12 were dismissed for other various reasons.

208 209

Discussion 9

210

Closed malpractice claims can be a useful quality improvement tool for identifying safety issues,

211

patterns and trends of injury, and strategies for prevention of related patient injuries.7 The

212

OMIC closed claims data reveal that anesthesia-related claims are relatively rare, with 63 closed

213

claims from 50 plaintiffs over 10.5 years despite the large number of surgeries performed

214

across the country each year by OMIC-insured ophthalmologists, practices, and surgicenters.

215

Anesthesia-related claims represented 2.8% (63/2227) of all total OMIC claims from 2008 to

216

2018 when the number of OMIC-insured ophthalmologists rose from 3939-5291. This number

217

is down from 3.2% of all claims in 1987-2005 (78/2474) during which time the number of OMIC

218

insured ophthalmologists rose from 877-3939.

219

While the low number of malpractice claims indicates that ophthalmic anesthesia care is

220

generally safe, there are important lessons that can inform a continuous process of

221

improvement aimed at maximally reducing the number of patient injuries.

222 223 224

Anesthesia-related complications can lead to severe injuries that have a devastating impact on

225

the plaintiff.1,2 Globe perforations were the most common injury in the cohort, accounting for

226

34% of defendant injuries. Patients with globe perforation injuries frequently had severe vision

227

loss or loss of the eye. The number of globe perforations in our data diminished in the 5.5 years

228

from 2013 to 2018 compared to the first 5 years of the study period, from 2008 to 2012. The

229

decreased number of globe perforations may be due to chance alone given the small numbers,

230

but it is notable that a switch to topical anesthesia occurred in many cataract practices during

10

231

this same time period. 8,9 Prospective trials are required to assess and compare the incidence

232

of ocular injury and surgical outcomes with various anesthesia techniques.

233 234

Thirteen patients died, accounting for 26% of complications and the second most untoward

235

event. Death occurred following retrobulbar, peribulbar, topical, and general anesthesia, as well

236

as sedation. Most of the plaintiffs who died had a known medical history of conditions such as

237

DM with end organ damage, CVD (e.g., hypertension, atherosclerotic cardiovascular disease,

238

myocardial infarction, congestive heart failure), or pulmonary disease. In two patients,

239

respiratory arrest, unresponsiveness, and death occurred immediately after a retrobulbar

240

block, and brainstem anesthesia was determined to be the etiology. Retrobulbar hemorrhage

241

(n=7) occurred both in patients taking anticoagulants (n=3) and those not taking anticoagulants

242

(n=4). The anticoagulants included anti-coagulant cascade inhibitors (warfarin, apixaban) and

243

anti-platelet drugs (aspirin and clopidogrel.)

244 245

The standard of care for medical clearance of patients undergoing ophthalmic surgery is slowly

246

evolving, with a focus on “optimizing risk reduction” instead of a blanket “medical clearance”.

247

There are increasing data to suggest that routine pre-operative medical evaluation and testing

248

of cataract surgery patients are, in some cases, unnecessary. The Centers for Medicare and

249

Medicaid Services recently eliminated the requirement that all patients undergoing surgery in

250

an ambulatory surgery center have a history and physical exam documented in the chart within

251

30 days of the procedure. 10 The new proposal requires that surgicenters create a written policy

252

defining which patients require pre-operative medical evaluation (i.e., history and physical

11

253

exam and lab testing) and allowing patients who are deemed low risk for operative

254

complications to skip this testing. There are data to support this change given the limited

255

benefit and high cost of this requirement for the vast majority of patients.11,12 When the patient

256

has significant medical comorbidities, however, it may be prudent, from both a clinical

257

standpoint as well as a risk management standpoint, to refer the patient to the primary care

258

physician, cardiologist, endocrinologist, or other appropriate medical specialist prior to surgery.

259

Engaging these physician consultants and using their expertise to optimize the patient’s general

260

health status before surgery may optimize the patients’ cardiovascular or pulmonary (or other)

261

systems to lower risk. Ophthalmologists may prefer to do the preoperative evaluation

262

themselves in some situations, especially given the difficulty of obtaining timely medical

263

evaluations and the lack of access in some locations to subspecialty care.

264

Fully preventing death related to ocular surgery and ocular anesthesia is not possible in the

265

population undergoing eye surgery given the age and co-morbidities. Cataract surgery in elderly

266

patients, and retinal cases involving patients with advanced diabetes-related co-morbidities,

267

carry intrinsic risks that cannot be completely eliminated. It is obviously important to pre-

268

operatively optimize the patient’s systemic health status with control of blood pressure,

269

coronary artery disease, blood sugar, pulmonary disease, and diabetic renal disease. But there

270

are significant obstacles to accomplishing this in many locations and situations. Some elderly

271

and sick patients have intrinsically unpredictable and unstable medical conditions. Some

272

ophthalmic surgery is urgent which places time constraints on medical evaluation and

273

stabilization. While there is more time before elective surgeries such as cataract removal,

274

patients may not be willing to invest the time, money, and effort to improve their health. 12

275

Ophthalmologists and primary care physicians may be falsely reassured by the low risk of

276

complications and the unproven value of routine labs and history and physical examinations in

277

the majority of patients but there are subsets of patients with serious co-morbidities or active

278

medical problems who do benefit from preoperative testing and management. Moreover,

279

delaying surgery and making it more time consuming and expensive carries potentially negative

280

consequences such as falls.

281

Two of the deaths appeared to be related to brainstem anesthesia, and both followed

282

retrobulbar anesthesia administered by an ophthalmologist. One plaintiff who could not keep

283

still for an A scan received the injection in the office. No licensed staff member was present to

284

monitor the response to the injection, and emergency response equipment was limited. CPR

285

was initiated while staff called 911. Paramedics arrived quickly and intubated the patient. The

286

defense’s toxicology expert felt that the medication was injected into the optic nerve. The

287

second case occurred in a surgery center where the anesthesia care was provided by an

288

anesthesiologist. While the ophthalmologist wondered if he had inadvertently given brainstem

289

anesthesia, the experts focused on the anesthesiologist whom they opined had over-sedated

290

the patient with propofol and inadequately monitored the response to the anesthesia and

291

sedation.

292

Retrobulbar hemorrhage was the third largest category of injury. Three of the plaintiffs with

293

retrobulbar hemorrhage injuries were taking antiplatelet medications (e.g., clopidogrel) or

294

clotting inhibitors (e.g., warfarin, apixaban, but 4 of 7 patients with retrobulbar hemorrhage

295

were not taking these medications. Continuing anti-coagulant treatment before and during eye

296

surgery is more common with phacoemulsification cataract surgery compared to other 13

297

surgeries, and with topical anesthesia compared to retrobulbar or peribulbar anesthesia.

298

Discontinuing anti-coagulants in the peri-operative period can lead to life-threatening

299

cardiovascular and neurological complications but continuing the anticoagulants elevates the

300

risk of injuries from hemorrhage. The surgeon needs to consult with both the physician who is

301

managing the patient’s medical condition(s) and the patient to address the associated risks of

302

each approach during the informed consent discussion. OMIC has created consent forms that

303

help patients understand the complexity of managing anti-coagulants during the perioperative

304

period. They provide a clear explanation to patients of the risks associated with both stopping

305

and continuing anticoagulants. Planning for urgent treatment of retrobulbar hemorrhage with

306

lateral cantholysis might help mitigate some injuries but extensive intraocular or retrobulbar

307

hemorrhage can be difficult to manage and can lead to a poor clinical outcome.

308 309

As expected, there were more ocular anesthesia claims from high volume procedures. Thus,

310

cataract surgery was most common surgical procedure noted in the closed claims followed by

311

retina surgery, including vitrectomy. General ophthalmological procedures, oculoplastics

312

procedures, strabismus surgery, and miscellaneous surgical procedures account for the

313

remaining cases.

314

Seventy-five percent of the claims or suits closed with no indemnity payments, which compares

315

favorably to industry standards.1 The cases that resulted in indemnity payments were nearly all

316

negotiated settlements; only one of the five cases that went to trial resulted in a plaintiff

317

verdict. Of note, the percentage of claims that were anesthesia-related in the OMIC database

318

(3%) is lower than the percentage in the literature for general surgical specialties (4%). 14

319 320 321

Our review of OMIC’s malpractice claims data supports recent recommended strategies to

322

lower the anesthesia-related risk to patients undergoing ocular surgery. 1-4,8,13 First, use the

323

least invasive form of anesthesia possible, weighing carefully the need for needle-based

324

anesthesia, which can lead to globe perforations and retrobulbar hemorrhage. 1,2 Some

325

ophthalmic surgical cases and patients require needle-based anesthesia, but some can be

326

managed with less invasive forms of anesthesia such as topical anesthesia. Second, obtain or

327

perform preoperative evaluations with the goal of optimizing the patient’s health. Consult with

328

primary care physicians and medical specialists, if available, for patients with serious systemic

329

diseases such as cardiovascular, endocrinological, renal, hematologic, rheumatologic, or

330

pulmonary diseases. Inform patients with conditions such as DM and CVD which are known to

331

increase mortality of the risk-reducing advice given by medical specialists. Clarify that it is

332

impossible to eliminate all risk, and the goal is to minimize risk. Consult with the patient’s

333

primary care or cardiologist to determine the safest plan for managing the peri-operative anti-

334

coagulants and use a specific consent form for those patients who take anti-coagulants to

335

document discussion regarding the risks of both maintaining and stopping the use of

336

anticoagulants. 14 Include in the procedure-specific consent form the rare but serious risks of

337

anesthesia (e.g., death, globe perforation, orbital and ocular hemorrhage, and optic nerve

338

injuries). OMIC has procedure-specific consent forms available on its website. 15 Consider

339

performing known medically high-risk cases in a hospital setting where higher levels of

340

emergency back-up are available compared to a surgicenter setting. Be prepared to manage 15

341

complications such as brainstem anesthesia with CPR or bag valve mask respirations or vision-

342

threatening retrobulbar hemorrhage by superior and inferior lateral canthal tendon cantholysis

343

to relieve increased orbital pressure. Communicating with anesthesia providers about patients

344

on anticoagulants and those with high myopia (i.e., long axial length) can be helpful. Consider

345

doing a cut-down block in these situations, in which peribulbar anesthesia is administered via a

346

blunt cannula through a small conjunctival peritomy after the patient is prepped and draped.

347

Confirm that new anesthesia providers who perform blocks are well trained, monitored during

348

their early cases in a facility, and can consult with other anesthesia providers in difficult cases.

349

Calmly address patients who have pain, anxiety, or movement during surgery and clarify with

350

the anesthesia team the need for additional sedation. Keep in mind that, although rare, local

351

infiltration of anesthesia to lids can result in globe perforation. Finally, maintaining vigilance

352

and situational awareness, especially during any type of periocular injection, including lid

353

anesthesia, may help mitigate the chance of a complication. A seemingly innocuous injection of

354

anesthesia for a laser procedure or a chalazion incision and drainage can be complicated by

355

globe perforation as was seen in several of our closed claims.

356

Our paper has several limitations. First, analyzing malpractice claims differs greatly from a

357

retrospective analysis of clinical data or an epidemiological study. Medical experts who provide

358

opinions about a malpractice claim know the plaintiff’s outcome and are participating in an

359

adversarial process. Plaintiffs typically testify to the impact of the alleged harm on their daily

360

life, providing information that is not readily available in the medical record. This process can

361

introduce multiple confounders, biases, and allegations concerning the severity of injuries. The

362

profitability of a case and the willingness of the plaintiff and his/her lawyer to pursue litigation 16

363

impact whether a claim or suit is filed or not, as well as the claim resolution. The nature of the

364

physician-patient relationship may incite or inhibit the filing of a claim or lawsuit irrespective of

365

the clinical outcome of a procedure. For these reasons, retrospective closed claim data must be

366

interpreted with these limitations in mind. While it is not a statistically valid source of

367

epidemiological data, the information is still valuable and actionable.

368

A second limitation is that there is uncertainty about the exact cause for some of the injuries

369

reported here. In particular, the role of sedation or over-sedation, is hard to quantify. For

370

example, in one case, a patient who received topical anesthesia as well as intravenous sedation

371

died and there was an allegation of over-sedation. Attributing an injury to the anesthesia, or to

372

the sedation medications which are frequently administered in conjunction with non-general

373

anesthesia cases, or to progression of a patient’s underlying medical condition is sometimes

374

difficult, especially in retrospection. Similarly, post-operative optic nerve injury can in some

375

cases be directly attributed to an optic nerve sheath penetration and hemorrhage but in some

376

cases may be related to optic nerve diseases such as ischemic optic neuropathy. Ophthalmic

377

surgical patients frequently have risk factors for increased mortality including advanced age as

378

well as co-existent medical problems such as DM, HTN, or ASCVD.

379

A third limitation of our study is that our data also do not include claims that may have been

380

made against non-OMIC insured entities such as the anesthesiologist, nurse anesthetist, the

381

anesthesiology group contracted to provide anesthesia services, or the hospital. Thus, our study

382

likely underestimates the number of anesthesia-related closed claims cases.

383

17

384

In summary, anesthesia-related claims are uncommon but serious anesthesia-related injuries

385

do occur. The population of patients undergoing ophthalmic surgery includes elderly and sick

386

patients making some morbidity and mortality unavoidable. Strategies described herein may

387

help to reduce potential complications and help to maximize patient safety and minimize

388

professional liability exposure of ophthalmologists, anesthesia providers, surgicenters, and

389

medical practices.

390

This study adheres to the Declaration of Helsinki.

391

The authors have no financial or other conflicts of interest to declare.

392 393 394 395 396 397 398 399 400 401 402 403 404 405 406 407

References 1) Nanji, K.C., Roberto, S.A., Morley, M.G. and Bayes, J., 2018. Preventing adverse events in cataract surgery: recommendations from a Massachusetts expert panel. Anesthesia & Analgesia, 126(5), pp.1537-1547. 2) Roberto, S.A., Bayes, J., Karner, P.E., Morley, M.G. and Nanji, K.C., 2018. Patient harm in cataract surgery: a series of adverse events in Massachusetts. Anesthesia & Analgesia, 126(5), pp.1548-1550. 3) Nanji, K, Morley, M, Betsy Lehman Center for Patient safety, Improving Patient Safety in Cataract Surgery, Published September 2016, https://betsylehmancenterma.gov/initiatives/cataract-surgery-initiative Accessed 11/12/19 4) Pennsylvania Patient safety Advisory, Pennsylvania Patient Safety Reporting System (PAPSRS) Patient Safety Advisory—Vol. 4, No. 1 http://patientsafety.pa.gov/ADVISORIES/Pages/200703_18.aspx Accessed 7/27/2019 5) Ophthalmic Mutual Insurance Company 2018 Members Report. Ophthalmic Mutual

408

Insurance Company, https://www.omic.com/wp-content/uploads/2018/10/2018-

409

Members-Report.pdf Accessed 2/19/19

410

6) American Society of Anesthesiologists Physical Status Classification

411

https://www.asahq.org/standards-and-guidelines/asa-physical-status-classification-

412

system. Accessed September 15, 2019 18

413 414 415 416

7) Anesthesia Quality Institute. American Society of Anesthesiologists, About Closed Claims https://www.aqihq.org/ACCMain.aspx accessed 7/21/19 8) Karen Posner, PhD, Lori Lee, MD, Anesthesia malpractice claims associated with eye

417

surgery and eye Injury- highlights from the anesthesia closed claims project data request

418

service https://www.aqihq.org/closedclaimsPDF/Click%20here%20for_5PDF

419

American Society of Anesthesiologists November 2014, 78;11 28-30 2014

420

Accessed 2/19/19

421

9) Severe adverse events associated with local anaesthesia in cataract surgery: 1-year

422

national survey of practice and complications in the UK Richard M H Lee, John R

423

Thompson and Tom Eke Br J Ophthalmol published online September 24, 2015

424

10) Centers for Medicare and Medicaid Services Omnibus Burden Reduction Conditions

425

Participation Final Rule. https://www.cms.gov/newsroom/fact-sheets/omnibus-burden-

426

reduction-conditions-participation-final-rule-cms-3346-f

427

428

11) Keay,l., Lindsley, K., Katz, J., Schein, O., Routine preoperative medical testing for

429

cataract surgery. Cochrane Database Syst rev 2019 Jan 8; 1: CD007293.doi:

430

10.1002/14651858.CD.007293.pub4

431

12) Chen, CL, Lin, GA, Bardach, NS, et al Preoperative medical testing in Medicare patients

432

undergoing cataract surgery. NEJM 2015 Apr 16; 372(16):1530-8. Doi:

433

10.1056/NEJMsa1410846

19

434 435 436 437 438 439

13) Menke, A., Salz, J., Ocular Anesthesia-Related Claims: Causes and Outcomes. OMIC Digest 2006 16(1): 1-5 14) Menke, A, Ophthalmic Mutual Insurance Company, OMIC consents- anticoagulants https://www.omic.com/anticoagulant-consent 15) Menke, A, Ophthalmic Mutual Insurance Company, Consent forms for cataract surgery anesthesia https://www.omic.com/risk-management/consent-forms/

440

441

20

1 2

Table 1 Table 1: Summary of Demographics of Closed Claims Data 2008-2018 Number of plaintiffs (N) Number of claims or suits (N)

50 63

Plaintiff age in years (mean, range)median?

58.0, (2-81)

Gender, N (%) Female 26 (52%) Male 21 (42) Uncertain 3 (6%)

3

Time to open claim from occurrence in days; (mean, range) 380 (1-832) Time to close claim from occurrence in days; (mean, range) 1299 (433-3722) Table 1 Legend: Summary of demographics of closed claims data.

1 2

Table 2 Table 2: Summary of Closed Claims data 2008-2018 Types of plaintiff injuries (N)

(N)

(%)

Globe perforation Death Retrobulbar hemorrhage Optic nerve injury Vascular occlusion, pain, movement during surgery resulting in injury Numbness, diplopia, tooth loss total

17 13 7 4 2 each, 6 total

34% 26% 14% 8% 4% each, 12% total

1 each, 3 total 50

2% each, 6% total 100%

Type of anesthesia (N)

Retrobulbar Peribulbar Local infiltration Topical General Unknown, but not general Total

16 16 6 5 5 2 50

32% 32% 12% 10% 10% 4% 100%

Administrator of all retrobulbar or peribulbar anesthesia blocks (N=32)

Ophthalmologist

27

85%

Anesthesiologist CRNA Total

3 2 32

9% 6% 100%

Retrobulbar Peribulbar Peri or RB- uncertain type

10 5 2

59% 29% 12%

Ophthalmologist Anesthesiologist CRNA

12 3 2

70% 18% 12%

Types of blocks associated with globe perforation (n=17)

Administrator of blocks in perforation cases (n=17)

Location of Procedure Hospital inpatient OR Office based laser or minor procedure room Hospital based surgicenter Non-hospital based surgicenter Location not recorded

1 4

Cataract/IOL surgery Retina surgery (vitrectomy/SB) Laser surgery Lid surgery/oculoplastic Pterygium surgery Strabismus Total procedures

24 12

48% 24%

5 5 3 1 50

10% 10% 6% 2% 100%

9 18 18

Procedure type (N)

Disposition (N)

Closed with payment Settled with annuity 1 Settled with lump sum 14 Plaintiff verdict- trial 1 Closed without payment Dismissed Without prejudice With prejudice Lack of prosecution Judgement defensemotion summary judgement Defense verdict-trial

3 4 5 6

2% 22% 2%

24

38%

5 10 3 1

8% 16% 5% 2%

4

6%

Total disposition 63 *101% Table 2 Legend: Summary data regarding the closed claims cases in the OMIC database, 2008-2018. *Percentage > 100 due to rounding.

2

Actionable steps to Minimize Anesthesia-Related Complications in Ocular Surgery Number Steps Comment 1 Maintain situational awareness of the location of Anesthesia injections to the the needle tip when performing even a “simple” eyelid or peribulbar or periocular anesthetic injection. retrobulbar space can occur less than a millimeter from the globe. 2 Use the least invasive method of anesthesia when Topical anesthesia, while possible. not always possible, lowers chance of perforation and other needle-related complications. 3 Consider medical consultation for patients with Primary care or specialty active systemic diseases. consultations to optimize health can benefit the anesthesia team, the eye surgeon, and the patient. 4 Manage perioperative anticoagulants in concert Both stopping and with the patients’ doctors. maintaining anticoagulants in the perioperative period carry risk. Help the patient understand the risks. 5 Consider using a hospital based OR for patients who Hospitals have significantly may require medical support or resuscitation. more resources to manage complex or unstable medical patients compared to free standing surgicenters. 6 Be prepared to manage anesthesia related Surgicenter or office-based complications such as retrobulbar hemorrhage (e.g., settings will have the lateral canthotomy) or brainstem anesthesia (e.g., equipment to manage these CPR with bag mask respirations). complications. Prompt recognition is critical. 7 Communicate with anesthesia providers in cases of Notifying anesthesia of a high myopia with elongated globes. posterior staphyloma may help reduce perforations. 8 Review all new anesthesia providers’ experience New providers should be and expertise in administering periocular blocks. monitored to assure quality and safety. 9 Consider conjunctival cut down and blunt cannula Potentially lower risk of injection of anesthetic in elongated eyes. globe perforation in high risk eyes.

10

Optimize surgical consent forms to inform patients Informs patients and about anesthesia risks documents risk discussions. Table 3: Actionable steps to minimize anesthesia-related complications in ocular surgery.